UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

ERK: A Key Player in the Pathophysiology of Cardiac Hypertrophy

International journal of molecular sciences, 2019-05, Vol.20 (9), p.2164

2019

Volltextzugriff (PDF)

Cellular and molecular mechanisms of HGF/Met in the cardiovascular system

Clinical science (1979), 2015-12, Vol.129 (12), p.1173-1193

2015

Volltextzugriff (PDF)

NMDA Receptor and Its Emerging Role in Cancer

International journal of molecular sciences, 2023-01, Vol.24 (3), p.2540

2023

Volltextzugriff (PDF)

The MET Oncogene: Thirty Years of Insights into Molecular Mechanisms Driving Malignancy

Pharmaceuticals (Basel, Switzerland), 2024-04, Vol.17 (4), p.448

2024

Volltextzugriff (PDF)

HGF and MET: From Brain Development to Neurological Disorders

Frontiers in cell and developmental biology, 2021-06, Vol.9

2021

Volltextzugriff (PDF)

MET Oncogene Enhances Pro-Migratory Functions by Counteracting NMDAR2B Cleavage

Cells (Basel, Switzerland), 2023-12, Vol.13 (1), p.28

2023

Volltextzugriff (PDF)

Two-Chains Tissue Plasminogen Activator Unifies Met and NMDA Receptor Signalling to Control Neuronal Survival

International journal of molecular sciences, 2021-12, Vol.22 (24), p.13483

2021

Volltextzugriff (PDF)

The Long-Lasting Protective Effect of HGF in Cardiomyoblasts Exposed to Doxorubicin Requires a Positive Feed-Forward Loop Mediated by Erk1,2-Timp1-Stat3

International journal of molecular sciences, 2020-07, Vol.21 (15), p.5258

2020

Volltextzugriff (PDF)

The PSI Domain of the MET Oncogene Encodes a Functional Disulfide Isomerase Essential for the Maturation of the Receptor Precursor

International journal of molecular sciences, 2022-10, Vol.23 (20), p.12427

2022

Volltextzugriff (PDF)

Engineering, Characterization, and Biological Evaluation of an Antibody Targeting the HGF Receptor

Frontiers in immunology, 2021-12, Vol.12, p.775151-775151

2021

Volltextzugriff (PDF)

Identification of novel circulating microRNAs in advanced heart failure by next‐generation sequencing

ESC Heart Failure, 2021-08, Vol.8 (4), p.2907-2919

2021

Volltextzugriff (PDF)

Ghrelin and des-acyl ghrelin promote differentiation and fusion of C2C12 skeletal muscle cells

Molecular biology of the cell, 2007-03, Vol.18 (3), p.986-994

2007

Volltextzugriff (PDF)

Validation of met as a therapeutic target in alveolar and embryonal rhabdomyosarcoma

Cancer research (Chicago, Ill.), 2006-05, Vol.66 (9), p.4742-4749

2006

Volltextzugriff (PDF)

HGF/Met Axis in Heart Function and Cardioprotection

Biomedicines, 2014-10, Vol.2 (4), p.247-262

2014

Volltextzugriff (PDF)

Hepatocyte Growth Factor Acts as a Motogen and Guidance Signal for Gonadotropin Hormone-Releasing Hormone-1 Neuronal Migration

The Journal of neuroscience, 2007-01, Vol.27 (2), p.431-445

2007

Volltextzugriff (PDF)

A New Transgenic Mouse Model of Heart Failure and Cardiac Cachexia Raised by Sustained Activation of Met Tyrosine Kinase in the Heart

BioMed research international, 2016-01, Vol.2016 (2016), p.1-13

2016

Volltextzugriff (PDF)

Activated Met signalling in the developing mouse heart leads to cardiac disease

PloS one, 2011-02, Vol.6 (2), p.e14675

2011

Volltextzugriff (PDF)

Ezrin Is an Effector of Hepatocyte Growth Factor-Mediated Migration and Morphogenesis in Epithelial Cells

The Journal of cell biology, 1997-07, Vol.138 (2), p.423-434

1997

Volltextzugriff (PDF)

Bortezomib-mediated proteasome inhibition as a potential strategy for the treatment of rhabdomyosarcoma

European journal of cancer (1990), 2008-04, Vol.44 (6), p.876-884

2008

Volltextzugriff (PDF)

Agonistic monoclonal antibodies against the Met receptor dissect the biological responses to HGF

Journal of cell science, 1998-01, Vol.111 ( Pt 2) (2), p.237-247

1998

Volltextzugriff (PDF)

MET Oncogene Controls Invasive Growth by Coupling with NMDA Receptor

Cancers, 2022-09, Vol.14 (18), p.4408

2022

Volltextzugriff (PDF)

Anti-Differentiation Effect of Oncogenic Met Receptor in Terminally-Differentiated Myotubes

Biomedicines, 2015-02, Vol.3 (1), p.124-137

2015

Volltextzugriff (PDF)

Conditional Activation of MET in Differentiated Skeletal Muscle Induces Atrophy

The Journal of biological chemistry, 2007-03, Vol.282 (9), p.6812-6822

2007

Volltextzugriff (PDF)

An In vivo Model of Met-Driven Lymphoma as a Tool to Explore the Therapeutic Potential of Met Inhibitors

Clinical cancer research, 2008-04, Vol.14 (7), p.2220-2226

2008

Volltextzugriff (PDF)

1 – 25 von 62

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(55)

Publikationsform

Artikel
(61)
Buchkapitel
(1)

Sprache

Englisch
(62)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

ERK: A Key Player in the Pathophysiology of Cardiac Hypertrophy

Cellular and molecular mechanisms of HGF/Met in the cardiovascular system

NMDA Receptor and Its Emerging Role in Cancer

The MET Oncogene: Thirty Years of Insights into Molecular Mechanisms Driving Malignancy

HGF and MET: From Brain Development to Neurological Disorders

MET Oncogene Enhances Pro-Migratory Functions by Counteracting NMDAR2B Cleavage

Two-Chains Tissue Plasminogen Activator Unifies Met and NMDA Receptor Signalling to Control Neuronal Survival

The Long-Lasting Protective Effect of HGF in Cardiomyoblasts Exposed to Doxorubicin Requires a Positive Feed-Forward Loop Mediated by Erk1,2-Timp1-Stat3

The PSI Domain of the MET Oncogene Encodes a Functional Disulfide Isomerase Essential for the Maturation of the Receptor Precursor

Engineering, Characterization, and Biological Evaluation of an Antibody Targeting the HGF Receptor

Identification of novel circulating microRNAs in advanced heart failure by next‐generation sequencing

Ghrelin and des-acyl ghrelin promote differentiation and fusion of C2C12 skeletal muscle cells

Validation of met as a therapeutic target in alveolar and embryonal rhabdomyosarcoma

HGF/Met Axis in Heart Function and Cardioprotection

Hepatocyte Growth Factor Acts as a Motogen and Guidance Signal for Gonadotropin Hormone-Releasing Hormone-1 Neuronal Migration

A New Transgenic Mouse Model of Heart Failure and Cardiac Cachexia Raised by Sustained Activation of Met Tyrosine Kinase in the Heart

Hepatocyte Growth Factor-mediated satellite cells niche perturbation promotes development of distinct sarcoma subtypes

Activated Met signalling in the developing mouse heart leads to cardiac disease

Ezrin Is an Effector of Hepatocyte Growth Factor-Mediated Migration and Morphogenesis in Epithelial Cells

Bortezomib-mediated proteasome inhibition as a potential strategy for the treatment of rhabdomyosarcoma

Agonistic monoclonal antibodies against the Met receptor dissect the biological responses to HGF

MET Oncogene Controls Invasive Growth by Coupling with NMDA Receptor

Anti-Differentiation Effect of Oncogenic Met Receptor in Terminally-Differentiated Myotubes

Conditional Activation of MET in Differentiated Skeletal Muscle Induces Atrophy

An In vivo Model of Met-Driven Lymphoma as a Tool to Explore the Therapeutic Potential of Met Inhibitors

Suchergebnisse filtern